WEBSITECHANGES

Website Changes

---

03/09/2019

Optune Open House

---

03/05/2019

Brain tumor advocacy alert - we need you to watch this video Wednesday Morning 3/6/19 at 9am Eastern Time!

---

03/02/2019

Parkinson’s and cancer hope from implant drilled into skull to deliver drugs with pinpoint precision

---

03/02/2019

The sneaky way estrogen drives brain metastasis in non-estrogen-dependent breast cancers

---

02/27/2019

Medicare meeting about Optune! Tune in this Wednesday March 6, 2019

---

02/23/2019

Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.

---

02/22/2019

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

---

02/22/2019

Tocagen is looking for patients with high grade glioma (glioblastoma or anaplastic astrocytoma) and caregivers to participate in an advisory board event in San Diego from March 20-21st.

---

02/21/2019

Major Advocacy Issure: Optune

---

02/21/2019

Malaria drug successfully treats 26-year-old brain cancer patient

---

02/17/2019

why some brain tumors respond to immunotherapy

---

02/17/2019

Confirmation of high therapeutic effect in doctor-led clinical trials of viral therapy for brain tumor - Application for approval for the manufacture and marketing of the first cancer treatment viral drug in Japan -

---

02/15/2019

Statins, NSAIDS Have No Apparent Survival Benefit for Grade IV Glioma

---

02/14/2019

Contractor Advisory Committee (CAC) Meeting Information - Tumor Treatment Field Therapy (L34823)

---

02/14/2019

University of Minnesota First in U.S. to Offer New Targeted Therapy for Recurrent Brain Tumors

---

02/13/2019

Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation

---

02/13/2019

Progesterone is more effective than dexamethasone in prolonging overall survival and preserving neurologic functions in experimental animals with orthotopic glioblastoma allografts.

---

02/13/2019

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema.

---

02/13/2019

Race influences survival in glioblastoma patients with KPS =?80 and associates with genetic markers of retinoic acid metabolism.

---

02/13/2019

Oncotelic Reports that It`s Proprietary In-Situ Cancer Vaccine Improved Survival over Standard Chemotherapy in Patients with Recurrent Metastatic Pancreas Cancer and Recurrent High Grade Glioma

---

02/12/2019

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review

---

02/12/2019

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

---

02/11/2019

Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial

---

02/10/2019

Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55

---

02/06/2019

Brain Tumor `Pied Piper` Device Gains Breakthrough Status

---